Protect from direct sunlight and excessive heat
Emerging research has also identified possible links between GLP-1 medications and serious conditions affecting the eyes, gallbladder, and pancreas
Clinical trials show patients on semaglutide consume approximately 5001,000 calories less per day compared to placebo groups, even without deliberate restriction
In Progress (2025): California, Massachusetts, Illinois, Virginia, Texas and New Hampshire have introduced or reintroduced similar legislation targeting underage access to performance-enhancing supplements
A 2025 randomized pragmatic trial found that semaglutide delivered a 15% greater reduction in HbA1c than hormone-based comparators, underscoring the need to adjust insulin or secretagogue dosing to reduce hypoglycemia risk
contact your GP for persistent abdominal pain, vomiting, hypoglycaemia symptoms, or visual changes